Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.17
(4.85%)
HKD 0.17
(4.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.43 Million HKD | 35.11% |
| 2022 | -20.7 Million HKD | 14.99% |
| 2021 | -24.35 Million HKD | -14.11% |
| 2020 | -21.34 Million HKD | 17.97% |
| 2019 | -26.01 Million HKD | -124.03% |
| 2018 | -11.61 Million HKD | -68.57% |
| 2017 | -6.88 Million HKD | -730.0% |
| 2016 | -830 Thousand HKD | 96.4% |
| 2015 | -23.06 Million HKD | 40.67% |
| 2014 | -38.87 Million HKD | -2.72% |
| 2013 | -37.84 Million HKD | 57.37% |
| 2012 | -88.77 Million HKD | 32.54% |
| 2011 | -131.6 Million HKD | -1613.59% |
| 2010 | 8.69 Million HKD | -35.55% |
| 2009 | 13.49 Million HKD | -97.8% |
| 2008 | 612.44 Million HKD | 7222.32% |
| 2007 | -8.59 Million HKD | -116.6% |
| 2006 | -3.97 Million HKD | -31.59% |
| 2005 | -3.01 Million HKD | 41.41% |
| 2004 | -5.14 Million HKD | 88.59% |
| 2003 | -45.12 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -13.43 Million HKD | 35.11% |
| 2023 Q1 | -3.1 Million HKD | 76.51% |
| 2023 Q2 | -6.21 Million HKD | -100.0% |
| 2023 Q3 | -3.64 Million HKD | 41.34% |
| 2023 Q4 | -7.28 Million HKD | -100.0% |
| 2022 Q3 | -6.61 Million HKD | 14.23% |
| 2022 Q4 | -13.22 Million HKD | -100.0% |
| 2022 Q1 | -3.85 Million HKD | 60.01% |
| 2022 Q2 | -7.7 Million HKD | -100.0% |
| 2022 FY | -20.7 Million HKD | 14.99% |
| 2021 FY | -24.35 Million HKD | -14.11% |
| 2021 Q1 | -7.35 Million HKD | 12.47% |
| 2021 Q2 | -14.71 Million HKD | -100.0% |
| 2021 Q3 | -4.85 Million HKD | 66.98% |
| 2021 Q4 | -9.63 Million HKD | -98.33% |
| 2020 Q2 | -7.09 Million HKD | -100.0% |
| 2020 FY | -21.34 Million HKD | 17.97% |
| 2020 Q3 | -7.24 Million HKD | -2.11% |
| 2020 Q1 | -3.54 Million HKD | 61.38% |
| 2020 Q4 | -8.4 Million HKD | -15.96% |
| 2019 FY | -26.01 Million HKD | -124.03% |
| 2019 Q1 | -5.91 Million HKD | 23.59% |
| 2019 Q2 | -11.83 Million HKD | -100.0% |
| 2019 Q3 | -10.26 Million HKD | 13.24% |
| 2019 Q4 | -9.19 Million HKD | 10.44% |
| 2018 Q3 | -7.74 Million HKD | -35.27% |
| 2018 Q4 | -7.74 Million HKD | 0.0% |
| 2018 Q2 | -5.72 Million HKD | 0.0% |
| 2018 Q1 | -5.72 Million HKD | 43.19% |
| 2018 FY | -11.61 Million HKD | -68.57% |
| 2017 FY | -6.88 Million HKD | -730.0% |
| 2017 Q3 | -10.07 Million HKD | -313.95% |
| 2017 Q2 | -2.43 Million HKD | 0.0% |
| 2017 Q1 | -2.43 Million HKD | 62.86% |
| 2017 Q4 | -10.07 Million HKD | 0.0% |
| 2016 Q4 | -6.55 Million HKD | 0.0% |
| 2016 Q1 | -4.77 Million HKD | 57.24% |
| 2016 Q2 | -4.77 Million HKD | 0.0% |
| 2016 Q3 | -6.55 Million HKD | -37.26% |
| 2016 FY | -830 Thousand HKD | 96.4% |
| 2015 Q1 | -4.34 Million HKD | 44.17% |
| 2015 Q3 | -11.16 Million HKD | -156.93% |
| 2015 Q2 | -4.34 Million HKD | 0.0% |
| 2015 Q4 | -11.16 Million HKD | 0.0% |
| 2015 FY | -23.06 Million HKD | 40.67% |
| 2014 Q1 | -8.35 Million HKD | 0.0% |
| 2014 FY | -38.87 Million HKD | -2.72% |
| 2014 Q4 | -7.78 Million HKD | 0.0% |
| 2014 Q3 | -7.78 Million HKD | 6.86% |
| 2014 Q2 | -8.35 Million HKD | 0.0% |
| 2013 FY | -37.84 Million HKD | 57.37% |
| 2013 Q2 | -10.8 Million HKD | 12.18% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q1 | -12.3 Million HKD | 14.66% |
| 2012 Q2 | -7.14 Million HKD | 0.0% |
| 2012 Q4 | -14.42 Million HKD | -101.92% |
| 2012 Q3 | -7.14 Million HKD | 0.0% |
| 2012 FY | -88.77 Million HKD | 32.54% |
| 2011 FY | -131.6 Million HKD | -1613.59% |
| 2010 FY | 8.69 Million HKD | -35.55% |
| 2009 FY | 13.49 Million HKD | -97.8% |
| 2008 FY | 612.44 Million HKD | 7222.32% |
| 2007 FY | -8.59 Million HKD | -116.6% |
| 2006 FY | -3.97 Million HKD | -31.59% |
| 2005 FY | -3.01 Million HKD | 41.41% |
| 2004 FY | -5.14 Million HKD | 88.59% |
| 2003 FY | -45.12 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | -3.73 Million HKD | -259.39% |
| China Overseas Nuoxin International Holdings Limited | -2.63 Million HKD | -409.636% |
| Prosperous Future Holdings Limited | -30.27 Million HKD | 55.622% |
| Huasheng International Holding Limited | 994 Thousand HKD | 1451.509% |
| Fourace Industries Group Holdings Limited | 39.7 Million HKD | 133.831% |
| Evergreen Products Group Limited | 81.06 Million HKD | 116.573% |
| EC Healthcare | 186.03 Million HKD | 107.221% |
| Ming Fai International Holdings Limited | 144.06 Million HKD | 109.325% |
| Blue Moon Group Holdings Limited | 130.43 Million HKD | 110.299% |
| SuperRobotics Holdings Limited | -7.88 Million HKD | -70.482% |
| Takbo Group Holdings Limited | 9.68 Million HKD | 238.681% |
| Hyfusin Group Holdings Limited | 138.63 Million HKD | 109.69% |